Prelude Capital Management’s Sagimet Biosciences SGMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,200	Closed	-$58.7K	–	1399
2024 Q3	$58.7K	Buy	21,200 +8,900	+72%	+$24.7K	﹤0.01%	1097
2024 Q2	$42.1K	Buy	12,300 +2,100	+21%	+$7.18K	﹤0.01%	1062
2024 Q1	$55.3K	Buy	+10,200	New	+$55.3K	﹤0.01%	1137